Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Weighted Average and Diluted): 2021-2025

Historic EPS (Weighted Average and Diluted) for Roivant Sciences (ROIV) over the last 4 years, with Sep 2025 value amounting to -$0.17.

  • Roivant Sciences' EPS (Weighted Average and Diluted) rose 45.16% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.58, marking a year-over-year decrease of 110.53%. This contributed to the annual value of -$0.75 for FY2025, which is 113.37% down from last year.
  • Roivant Sciences' EPS (Weighted Average and Diluted) amounted to -$0.17 in Q3 2025, which was up 48.48% from -$0.33 recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) peaked at $6.10 during Q4 2023, and registered a low of -$0.49 during Q4 2022.
  • For the 3-year period, Roivant Sciences' EPS (Weighted Average and Diluted) averaged around $0.61, with its median value being -$0.24 (2025).
  • In the last 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) soared by 1,344.90% in 2023 and then plummeted by 375.00% in 2025.
  • Roivant Sciences' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.41 in 2021, then dropped by 19.51% to -$0.49 in 2022, then soared by 1,344.90% to $6.10 in 2023, then slumped by 96.23% to $0.23 in 2024, then spiked by 45.16% to -$0.17 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.17 in Q3 2025, compared to -$0.33 in Q2 2025 and $0.23 in Q4 2024.